Metabolic risk profile among overweight and obese lactating women in Sweden

Anna Winkvist, Fredrik Bertz, Lars Ellegård, Ingvar Bosaeus, Hilde K Brekke, Anna Winkvist, Fredrik Bertz, Lars Ellegård, Ingvar Bosaeus, Hilde K Brekke

Abstract

Background: Obesity and cardiovascular diseases are increasing globally and any association between reproduction and these conditions is of concern. Unfortunately, little is known about normal levels of metabolic risk factors in women of different body mass index throughout the reproductive cycle. This study is one of the first to describe the metabolic risk profile of lactating overweight or obese women at 8-12 weeks postpartum.

Methods: During 2007-2009, 66 overweight or obese Swedish lactating women without known diseases underwent detailed measurements of their metabolic profiles, dietary intake and general health before entering a lifestyle intervention trial. Baseline measurements took place between 8-12 wk postpartum. Almost all women were exclusively breastfeeding their term infants.

Results: The women were regarded as healthy, as reflected in the absence of diagnosed diseases, their own perceptions and in normal hemoglobin, albumin and fasting plasma glucose values. Four women were diagnosed with metabolic syndrome. In these cases, underlying conditions included large waist circumference, low HDL cholesterol values, high triglyceride values and relatively high blood pressure. The metabolic profile differed between overweight and obese women; obese women had significantly higher levels of fasting insulin (p = 0.017), borderline higher HOMA values (p = 0.057) and significantly higher triglyceride values (p = 0.029), as well as larger waist and hip circumferences (p<0.001 and p<0.001). However, no significant differences between overweight and obese women were detected for LDL or total cholesterol levels. Overweight and obese women reported similar total energy and macronutrient intakes, but obese women tended to be less physically active (p = 0.081).

Conclusions: Among generally healthy lactating women, obesity as compared to overweight is associated with increased metabolic risk. This cut-off is thus important also in the early postpartum period, and obesity among these women should warrant proper health investigation. Macronutrient intake did not differ between the groups and, hence, cannot explain these differences.

Trial registration: ClinicalTrials.gov Identifier: NCT01343238.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. WHO (2000) Preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO Technical Report Series 894. Singapore: WHO. 252 p.
    1. Rasmussen KM, Abrams B, Bodnar LM, Butte NF, Catalano PM, et al. (2010) Recommendations for weight gain during pregnancy in the context of the obesity epidemic. Obstet Gynecol 116: 1191–1195.
    1. Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. Jama 303: 235–241.
    1. Gunderson EP, Jacobs DR, Jr., Chiang V, Lewis CE, Tsai A, et al.. (2009) Childbearing is associated with higher incidence of the metabolic syndrome among women of reproductive age controlling for measurements before pregnancy: the CARDIA study. Am J Obstet Gynecol 201: 177 e171–179.
    1. Lao XQ, Thomas GN, Jiang CQ, Zhang WS, Yin P, et al. (2006) Parity and the metabolic syndrome in older Chinese women: the Guangzhou Biobank Cohort Study. Clin Endocrinol (Oxf) 65: 460–469.
    1. Lawlor DA, Emberson JR, Ebrahim S, Whincup PH, Wannamethee SG, et al. (2003) Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women's Heart and Health Study and the British Regional Heart Study. Circulation 107: 1260–1264.
    1. Parikh NI, Cnattingius S, Dickman PW, Mittleman MA, Ludvigsson JF, et al.. (2010) Parity and risk of later-life maternal cardiovascular disease. Am Heart J 159: 215–221 e216.
    1. Kuh D, Hardy R (2002) A Life Course Approach to Women’s Health. Oxford: Oxford University Press. 419 p.
    1. Fahraeus L, Larsson-Cohn U, Wallentin L (1985) Plasma lipoproteins including high density lipoprotein subfractions during normal pregnancy. Obstet Gynecol 66: 468–472.
    1. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, et al. (2002) Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 87: 4231–4237.
    1. Vahratian A, Misra VK, Trudeau S, Misra DP (2010) Prepregnancy body mass index and gestational age-dependent changes in lipid levels during pregnancy. Obstet Gynecol 116: 107–113.
    1. Darmady JM, Postle AD (1982) Lipid metabolism in pregnancy. Br J Obstet Gynaecol 89: 211–215.
    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419.
    1. Gunderson EP, Hedderson MM, Chiang V, Crites Y, Walton D, et al. (2012) Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort. Diabetes Care 35: 50–56.
    1. Guelinckx I, Devlieger R, Beckers K, Vansant G (2008) Maternal obesity: pregnancy complications, gestational weight gain and nutrition. Obes Rev 9: 140–150.
    1. American College of Sports Medicine Position Stand (1998) The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 30: 975–991.
    1. Cameron AJ, Shaw JE, Zimmet PZ (2004) The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33: 351–375, table of contents.
    1. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama 287: 356–359.
    1. Kjos SL, Henry O, Lee RM, Buchanan TA, Mishell DR Jr (1993) The effect of lactation on glucose and lipid metabolism in women with recent gestational diabetes. Obstet Gynecol 82: 451–455.
    1. WHO (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation. Geneva: WHO Document Production Services. 50 p.
    1. Institute of Medicine and National Research Council (2009) Weight gain during pregnancy: Reexamining the guidelines. Washington: The National Academies Press. 854 p.
    1. Lain KY, Catalano PM (2007) Metabolic changes in pregnancy. Clin Obstet Gynecol 50: 938–948.
    1. Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347–355.
    1. Talayero BG, Sacks FM (2011) The role of triglycerides in atherosclerosis. Curr Cardiol Rep 13: 544–552.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir